Cargando…
Personalised medicine in asthma: time for action: Number 1 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
Asthma is a heterogeneous disease comprising several phenotypes driven by different pathways. To define these phenotypes or endotypes (phenotypes defined by mechanisms), an unbiased approach to clustering of various omics platforms will yield molecular phenotypes from which composite biomarkers can...
Autor principal: | Chung, Kian Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488697/ https://www.ncbi.nlm.nih.gov/pubmed/28954768 http://dx.doi.org/10.1183/16000617.0064-2017 |
Ejemplares similares
-
Personalised medicine in interstitial lung diseases: Number 6 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
por: Kokosi, Maria A., et al.
Publicado: (2018) -
Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017) -
Personalised medicine in sleep respiratory disorders: focus on
obstructive sleep apnoea diagnosis and treatment
por: Bonsignore, Maria R., et al.
Publicado: (2017) -
Personalised pulmonary rehabilitation in COPD
por: Wouters, Emiel F.M., et al.
Publicado: (2018) -
Personalised medicine in asthma: from curative to preventive medicine
por: Guilleminault, Laurent, et al.
Publicado: (2017)